Telix Pharmaceuticals (T3X.F) Q3 2021 Earnings

19AugConfirmed
Q3 2020
Q1 2021
Q3 2021
-0.07
-0.06
-0.05
-0.04

Details

Expected EPS
-0.061201893340755965
Actual EPS
-0.07344227200890714
Surprise EPS
-0.01
Surprise Percent
+20%

Description

Telix Pharmaceuticals (T3X.F) has reported earnings of -0.07344227200890714 per share for Q3 2021.

0 Comments

Share your thoughts